Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Rang in aandelen #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Aandeelprijs
$0.6
Laatst gesynchroniseerd: 2024-08-14
Marktkapitalisatie
$2.09M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
SG
Handel ASLAN Pharmaceuticals Limited (ASLN)

Categorie

Winst voor ASLAN Pharmaceuticals Limited (ASLN)
Winst in Mar 2024 TTM: $-34.90M
Volgens de meest recente financiële verslagen van ASLAN Pharmaceuticals Limited bedraagt de huidige winst van het bedrijf $-34.90M. In 2022 behaalde het bedrijf een winst van $-51.28M, een daling ten opzichte van de winst van 2021, die $-31.59M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van ASLAN Pharmaceuticals Limited van 2014 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-34.90M -20.84%
2023 $-44.09M -14.03%
2022 $-51.28M 62.34%
2021 $-31.59M 86.14%
2020 $-16.97M -63.63%
2019 $-46.66M 10.64%
2018 $-42.17M 3.58%
2017 $-40.71M 352.17%
2016 $-9.00M -32.43%
2015 $-13.33M 80.95%
2014 $-7.36M 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$5.27B -15,214.03%
US
$1.95B -5,689.14%
NL
- -
CH
- -
KR
$3.01B -8,712.20%
BE